PubRank

Y Iwaki

Author PubWeight™ 119.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Kidney transplantation under FK 506. JAMA 1990 7.45
2 The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet 1980 7.40
3 Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol 1978 6.88
4 Adeno-associated virus vectors can be efficiently produced without helper virus. Gene Ther 1998 3.77
5 Kidney transplantation under FK 506 immunosuppression. Transplant Proc 1991 3.31
6 Successful liver transplantation from crossmatch-positive donors. Transplant Proc 1981 2.80
7 Management of intestinal transplantation in humans. Transplant Proc 1992 2.62
8 Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver. J Virol 1999 2.37
9 Thoracic duct drainage before and after cadaveric kidney transplantation. Surg Gynecol Obstet 1979 2.33
10 Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood 1998 1.96
11 The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 1992 1.83
12 Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. Am J Pathol 1991 1.78
13 Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy. Transplant Proc 1991 1.77
14 Enhancement of human kidney allografts by cold B-lymphocyte cytotoxins. Lancet 1978 1.70
15 Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1. Transplantation 1992 1.68
16 Thoracic duct fistula and renal transplantation. Ann Surg 1979 1.60
17 A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology 1992 1.50
18 Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg 1980 1.45
19 The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation. Transplantation 1990 1.21
20 Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. Am J Pathol 1990 1.21
21 Immunopathology of antibodies as effectors of orthotopic liver allograft rejection. Semin Liver Dis 1992 1.09
22 The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis. Transplant Proc 1991 1.08
23 Evaluation of sequential serum interleukin-6 levels in liver allograft recipients. Transplantation 1994 1.06
24 Altered glycosylation of serum transferrin of patients with hepatocellular carcinoma. J Biol Chem 1989 1.03
25 Humoral rejection associated with antidonor lymphocytotoxic antibodies following liver transplantation. Transplant Proc 1993 1.03
26 The characterization of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis. Clin Orthop Relat Res 1994 1.01
27 Hyperacute rejection of a transplanted human heart. Transplantation 1981 0.98
28 Hydroxyapatite in revision of total hip replacements with massive acetabular defects: 4- to 10-year clinical results. J Bone Joint Surg Br 1997 0.94
29 Increased frequency of HLA-DRW2 in SLE. Lancet 1979 0.92
30 HLA-DR specifications in Japanese with juvenile-onset insulin-dependent diabetes mellitus. Diabetes 1982 0.91
31 A monoclonal antibody (L21-6) recognizing an invariant chain expressed on the cell surface in rats with the exception of the BN (RT1n): a study of tissue and strain distributions. Transplant Proc 1995 0.91
32 HLA-DR4 in Negro and Mexican rheumatoid arthritis patients. J Rheumatol 1982 0.90
33 Interleukin-6, a marker of preservation injury in clinical lung transplantation. J Heart Lung Transplant 1993 0.90
34 Donor and recipient age effect. Clin Transpl 1986 0.89
35 HLA antigens associated with systemic lupus erythematosus in Japan. J Rheumatol 1985 0.88
36 Update of the University of California at San Francisco experience with donor-specific blood transfusions. Transplant Proc 1982 0.88
37 Gene delivery to human chondrocytes by an adeno associated virus vector. J Rheumatol 2000 0.88
38 Reversal of transplant rejection by monoclonal antiblast antibody. Lancet 1983 0.87
39 B cell antibodies and crossmatching. Transplantation 1980 0.86
40 Reduction of accelerated failures by transfusion. Transplant Proc 1982 0.86
41 Immunohistochemical examination of lung cancers using monoclonal antibodies reacting with sialosylated Lewisx and sialosylated Lewisa. Virchows Arch A Pathol Anat Histopathol 1986 0.85
42 Retrospective tests of B-cold lymphocytotoxins and transplant survival at a single center. Transplant Proc 1979 0.85
43 Effect of sex on kidney transplants. Clin Transpl 1987 0.85
44 Evidence for a second B-cell locus separate from the DR locus. Transplant Proc 1978 0.84
45 Molecular cloning and characterization of the epididymis-specific glutathione peroxidase-like protein secreted in the porcine epididymal fluid. Biochim Biophys Acta 1997 0.84
46 Renal biopsy donor group: the influence of glomerulosclerosis on transplant outcomes. Transplant Proc 2005 0.84
47 Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma. Hepatogastroenterology 1991 0.84
48 Seventeen consecutive successful one-haplotype-matched living related first renal transplants using donor-specific blood transfusions. Transplantation 1982 0.83
49 Multiplexed analysis of polymorphisms in the HLA gene complex using bead array chips. Tissue Antigens 2004 0.83
50 Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance. Hepatology 1995 0.83
51 HLA matching effect in liver transplantation. Transplant Proc 1992 0.82
52 Incidence, characteristics, and outcome of recipients sensitized after donor-specific blood transfusions. Transplantation 1981 0.82
53 Comparative study of the sugar chains of gamma-glutamyltranspeptidases purified from human hepatocellular carcinoma and from human liver. J Biochem 1989 0.82
54 Pretreatment with donor-specific blood transfusions in related recipients with high MLC. Transplant Proc 1981 0.82
55 Benefits of posttransplantation monitoring of interleukin 6 in lung transplantation. Ann Thorac Surg 1993 0.82
56 Monoclonal antibody against A1 Lewis d antigen produced by the hybridoma immunized with a pulmonary carcinoma. Cancer Res 1982 0.81
57 Long-term survival of kidney grafts. Transplant Proc 1989 0.81
58 Normotest and abnormal prothrombin in liver transplantation. Liver 1995 0.81
59 Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private class I HLA determinants. Implications for computer-predicted acceptable and unacceptable donor mismatches in kidney transplantation. Transplantation 1990 0.80
60 Antibody response and allograft outcome with deliberate donor-specific blood transfusions. Transplant Proc 1982 0.80
61 Determinants of effectiveness of thoracic duct drainage for primary cadaver kidney transplantation. Transplant Proc 1981 0.79
62 Human leukocyte antigen-class II-positive human corneal epithelial cells activate allogeneic T cells. Invest Ophthalmol Vis Sci 1994 0.79
63 Sensitization effect. Clin Transpl 1986 0.79
64 Preliminary evidence of dual-marked lymphocytes in thoracic duct lymph fluid. Transplant Proc 1980 0.79
65 HLA-DR specificities among Japanese with several autoimmune diseases. Tissue Antigens 1982 0.79
66 A simple, rapid micro-latex fixation test. Clin Exp Immunol 1979 0.79
67 Racial effect on kidney transplants. Clin Transpl 1987 0.78
68 Carbohydrate structures of nonspecific cross-reacting antigen-2, a glycoprotein purified from meconium as an antigen cross-reacting with anticarcinoembryonic antigen antibody. Occurrence of complex-type sugar chains with the Gal beta 1----3GlcNAc beta 1----3Gal beta 1----4GlcNAc beta 1----outer chains. J Biol Chem 1989 0.78
69 Donor-specific serum transfusion prolongs survival of orthotopic liver transplantation in the rat. Transplant Proc 1989 0.78
70 Type 1 diabetes mellitus caused by treatment with interferon-beta. Intern Med 2000 0.78
71 Effects of tranilast on cultured rabbit corneal keratocytes and corneal haze after photorefractive keratectomy. Jpn J Ophthalmol 1999 0.78
72 Lymphapheresis in organ transplantation: preliminary report. Prog Clin Biol Res 1982 0.78
73 Lymphocyte trafficking using in situ hybridization and physioanatomy of the intestinal immune system after human small bowel transplantation. Transplant Proc 1992 0.78
74 Effect of tranilast eyedrops in preventing posterior capsule opacification: preliminary report. J Cataract Refract Surg 1999 0.78
75 2,3-Dihydro-5-hydroxy-2,2-dipentyl-4,6-di-tert-butylbenzofuran: design and evaluation as a novel radical-scavenging antioxidant against lipid peroxidation. Arch Biochem Biophys 1997 0.78
76 Successful living related kidney transplantation across an anti-donor HLA antibody. Transplant Proc 2006 0.78
77 Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts. Transplant Proc 1996 0.78
78 Effect of donor age on graft survival rates in pediatric living related transplants, first cadaver transplants, and regrafts. Transplant Proc 1994 0.77
79 The University of Pittsburgh: a three and three-quarter-year experience with cadaveric renal transplantation under the point system. Clin Transpl 1989 0.77
80 [The effect of tranilast on subepithelial corneal opacity after excimer laser keratectomy]. Nippon Ganka Gakkai Zasshi 1997 0.77
81 Cytotoxicity of anti-Fab antibodies against B lymphocytes in rheumatoid arthritis. Arthritis Rheum 1981 0.77
82 Diclofenac suppository pretreatment in prevention of vasovagal reflex-associated complications for infertile women undergoing local endometrial injury. Clin Exp Obstet Gynecol 2015 0.77
83 Improved graft survival following donor-specific blood transfusions. Transplant Proc 1981 0.77
84 The benefit and underutilization of sharing kidneys for better histocompatibility. Transplantation 1989 0.76
85 Carbohydrate binding specificity of immobilized Allomyrina dichotoma lectin II. J Biol Chem 1988 0.76
86 A monoclonal antibody cross-reactive with human platelets, megakaryocytes, and common acute lymphocytic leukemia cells. Blood 1983 0.76
87 The influence of donor age on kidney graft survival in the 1990s. Clin Transpl 1999 0.76
88 Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts. Transplant Proc 1999 0.76
89 Detection of TT virus DNA in human bile juice. Jpn J Infect Dis 2001 0.76
90 Serology of HLA. Transplant Proc 1981 0.76
91 The influence of matching in living-related transplants. Transplantation 1990 0.75
92 DR-bearing T lymphocytes in thoracic duct lymph. Clin Immunol Immunopathol 1981 0.75
93 Enhancing antibody in human renal transplantation. Transplant Proc 1979 0.75
94 Acute hemolytic anemia in liver and bone marrow transplant patients under FK 506 therapy. Transplant Proc 1991 0.75
95 Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report. Transplant Proc 1996 0.75
96 HLA-DR matching effect in orthotopic liver transplantation under FK 506. Transplant Proc 1993 0.75
97 Expression of blood group antigen (A, B, H, Le(a), Le(b)) on liver allografts. Transplant Proc 1992 0.75
98 The flow cytometry crossmatch in kidney transplantation. Clin Transpl 1987 0.75
99 Effect of preoperative thoracic duct drainage on canine kidney transplantation. J Invest Surg 1997 0.75
100 Association of B cold cytotoxins and anti-F (ab')2 antibodies with inhibition of mixed lymphocyte culture. Jpn J Med Sci Biol 1983 0.75
101 [Familial congenital heart diseases and HLA antigens (author's transl)]. Hokkaido Igaku Zasshi 1978 0.75
102 Clinical, electrophysiological, and serological overlap between Miller Fisher syndrome and acute sensory ataxic neuropathy. Acta Neurol Scand 2002 0.75
103 High performance liquid chromatography cyclosporine monitoring: a predictor of renal graft outcome. Transplant Proc 1998 0.75
104 Clinical transplants 1988. Overview. Clin Transpl 1988 0.75
105 Average P/F ratio during donor management for finding out the potential donor of lung procurement. Transplant Proc 2005 0.75
106 [Weight-height indices--studies on 13,502 'healthy' persons in Tokyo (author's transl)]. Nihon Ronen Igakkai Zasshi 1979 0.75
107 [Preparation of Fifty-items Neurotic Index (FNI), a new questionnaire for neurotic patients]. Seishin Shinkeigaku Zasshi 1992 0.75
108 Graft survival with high levels of cytotoxic antibodies. Transplant Proc 1981 0.75
109 Prospective HLA-DR matching in cadaveric renal transplants: a single center study. J Urol 1983 0.75
110 Identification of surface IgM as the target antigen of cold lymphocytotoxins. Tissue Antigens 1980 0.75
111 Parameters governing graft survival in pediatric renal transplant recipients. Transplant Proc 1995 0.75
112 Mouse popliteal lymph node assay for assessment of allergic and autoimmunity-inducing potentials of low-molecular-weight drugs. J Toxicol Sci 1999 0.75
113 In vitro study of BCX-34: a new human T-lymphocyte-specific purine phosphorylase inhibitor. Transplant Proc 1998 0.75
114 Dilutions and specificity analysis of pretransplant sera. Transplant Proc 1979 0.75
115 Perioperative cyclosporine: interaction with multifactorial variables and effect on allograft function. Transplant Proc 1986 0.75
116 The successful use of repeated courses of OKT3 for hepatic allograft rejection using %T3 cells to adjust dose. Transplant Proc 1989 0.75
117 Crossmatching with B and T cells and flow cytometry. Clin Transpl 1986 0.75
118 Unrelated donor-specific blood transfusions in human renal transplantation. Transplantation 1983 0.75
119 Effects of cold ischemia time on cadaver renal allografts. Transplant Proc 1993 0.75
120 Living donor lobar lung transplants and HLA matching: a preliminary report. Transplant Proc 1997 0.75
121 Effect of deliberate blood transfusions in cadaveric kidney allografts at a single center. J Urol 1982 0.75
122 [Non-verbal communication: communication with patients who are incapable of speech. Interpretation of subtle expressions by patients: through interactions with refractory neurologic diseases]. Kangogaku Zasshi 1985 0.75
123 Vaginal preparation with povidone iodine disinfection and saline douching as a safe and effective method in prevention of oocyte pickup-associated pelvic inflammation without spoiling the reproductive outcome: evidence from a large cohort study. Clin Exp Obstet Gynecol 2014 0.75
124 Sensitization after transplantation. Clin Transpl 1987 0.75
125 Hyperacute rejection following ABO-compatible orthotopic liver transplantation--a case report. Transplantation 1992 0.75
126 BCX-34: a novel T-cell selective immunosuppressant: purine nucleoside phosphorylase (PNP) inhibitor. Artif Organs 1996 0.75
127 Prolongation of second heart transplants in rats. Transplantation 1992 0.75
128 Trans-Pacific kidney shipment. Transplantation 1983 0.75
129 Multiscreen analysis of high PRA sera for antibodies towards public and private class I antigens: implications for computer-predicted acceptable donors for kidney transplant candidates. Transplant Proc 1991 0.75
130 Preservation. Clin Transpl 1986 0.75
131 Regrafts. Clin Transpl 1987 0.75
132 Crossreactivity between human and canine Ia antigens using a mouse monoclonal antibody (CIA). Transplantation 1983 0.75
133 Non-uniform effects of neurohumoral agents on the internal diameter in parallel and series arranged small arteries in rabbit hindlimb. Jpn J Physiol 1985 0.75
134 [A case of surgically cured acute dissecting aneurysm associated with Cushing's syndrome (author's transl)]. Kyobu Geka 1977 0.75
135 Examination of the clonal deletion hypothesis following transfusions in rat cardiac transplants. Transplant Proc 1987 0.75
136 Inhibition of mixed lymphocyte culture reaction by cold cytotoxins. Transplantation 1983 0.75
137 [Guidance criteria in enema application - for social rehabilitation of patients with colostomy. (1)]. Kango Gijutsu 1979 0.75
138 Examination of the clonal deletion hypothesis following transfusions in rat cardiac transplants. Transplantation 1987 0.75
139 [Therapy of hepatocellular carcinoma with UFT--clinical evaluation of its effect in the combination therapy with transcatheter arterial embolization or one shot therapy]. Gan To Kagaku Ryoho 1990 0.75
140 Donor-specific transfusion. Clin Transpl 1986 0.75
141 Antibodies to human immunoglobulin detected by hemolysis of human immunoglobulin-coated red blood cells. Tissue Antigens 1981 0.75
142 Differentiation of responses to allergenic and irritant compounds in mouse popliteal lymph node assay. J Toxicol Sci 2000 0.75
143 Do combined psychological stress examinations predict pregnancy outcome in an assisted reproductive technology program? Clin Exp Obstet Gynecol 2015 0.75
144 Improved graft survival with donor-specific transfusion pretreatment. Transplant Proc 1981 0.75
145 [A case of hepatocellular carcinoma responding to intraarterial infusion of epirubicin and mitomycin C]. Gan To Kagaku Ryoho 1992 0.75
146 [Effect of different concentrations of tranilast on posterior capsule opacification]. Nippon Ganka Gakkai Zasshi 2001 0.75
147 Association of anti-F(ab')2 antibodies with higher kidney transplant survival rates. Transplantation 1982 0.75
148 An alternative to cadaver kidney transplants for patients with insulin-dependent diabetes mellitus. Transplantation 1981 0.75
149 Red blood cell cold agglutinins and B lymphocyte cytotoxins in breast cancer sera. Vox Sang 1982 0.75
150 The transfusion effect. Clin Transpl 1988 0.75
151 Renal transplant graft survival results and HLA-A,B, DR mismatching. Transplant Proc 1995 0.75
152 Presensitization patterns in renal allograft recipients--a correlation with graft outcome. Ir J Med Sci 1980 0.75
153 Deliberate buffy-coat transfusions and the risk of antibody formation. Transplant Proc 1982 0.75
154 Posttransplant serum analysis in human kidney allografts. Transplant Proc 1981 0.75
155 Flow cytometry crossmatching for kidney transplantation. Clin Transpl 1988 0.75
156 Low-dose cyclosporine maintenance therapy after immunosuppressive induction in a rat cardiac transplant model. Transplantation 1988 0.75
157 Clinical kidney transplants, 1988. Immunol Lett 1989 0.75